About

About
soundbasis

A child born in South Korea in 2024 can expect to live 83.7 years — but only 65.5 of them in good health. The effort to close that 18.2-year gap is what we call longevity. soundbasis is a journal that asks, through three different lenses, whether those efforts stand on real evidence.

Years in good health
18.2 yrs
Age 0 Healthy life exp. 65.5 Life exp. 83.7
South Korea, 2024. Source: Statistics Korea, 2024 Life Tables. Healthy life expectancy excludes years lived with illness.
01 / WHAT

What is longevity?

The word used to mean simply living a long time. Today it points to something more specific.

Not lifespan, but
healthspan

Not how old you get, but how long you can walk, remember, and run your own life.

Not one disease at a time, but
aging itself

Instead of fighting cancer, heart disease, and dementia one by one, it targets the process of aging that they all share.

Not how it feels, but
what you measure

If you can't say what you're measuring and how it connects to real health, it's closer to a lifestyle habit than to longevity.

02 / WHY NOW

Why the sudden attention?

7yrs
Societies are aging fast

The time it took South Korea to go from an aged to a super-aged society. Germany took 37 years; France took 39.

9→12
Science has started to take aging apart

The hallmarks of aging described in the journal Cell grew from nine in 2013 to twelve in 2023. What can be taken apart can be targeted.

$3B
The money is pouring in

The amount one aging-research company launched with in 2022. Outside the lab, supplements, tests, and clinics are moving even faster.

03 / THE PROBLEM

Everything is sold under the same name

Interventions backed by decades of evidence and ones with thin human data both carry the "longevity" label. Put the scientist's lines side by side and the difference shows.

04 / HOW WE READ

So we ask three people the same question

The same topic leads to different conclusions depending on who's looking. Rather than hiding the disagreement behind a single score, soundbasis sets the three lines side by side.

Cellular Biology · Evidence
The Scientist
"What has actually been proven?"
Separates animal and cell data from human trials, and asks whether what changed is a blood marker or actual health.
Clinical Practice
The Clinician
"Could I recommend it to a patient?"
Looks at effect size, side effects, cost, and whether people can keep it up. Flags what is significant on paper but not usable in the clinic.
Longevity Economy · Capital
The Investor
"Are the money and the evidence on the same side?"
Follows where the money goes and what the business model is, and reads the gap between capital and evidence as a signal.
05 / OUR PROMISE

What we won't do

  • We don't recommend or disparage specific products, brands, or stocks.
  • We don't replace a medical diagnosis or an investment decision.
  • Any sponsored or advertising content is disclosed at the top.
  • When one of our lines changes, we keep the old sentence and the reason it changed.

Instead, we'll be honest about how far the evidence has come — and where expectation begins.